{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:36:20Z","timestamp":1792784180993,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Natural Science Foundation of Zhejiang Povince, China","award":["LGF 18H010001"],"award-info":[{"award-number":["LGF 18H010001"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jgar.2019.01.029","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T12:46:53Z","timestamp":1548852413000},"page":"47-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin\/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: A single-centre study in Zhejiang Province, China"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9311-6229","authenticated-orcid":false,"given":"Chun-Zhen","family":"Hua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fen","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Mei","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Fang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2019.01.029_bib0005","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/cid\/civ472","article-title":"Risk factors associated with infant deaths from pertussis: a case-control study","volume":"61","author":"Winter","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.01.029_bib0010","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1086\/589753","article-title":"Pathology and pathogenesis of fatal Bordetella pertussis infection in infants","volume":"47","author":"Paddock","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.01.029_bib0015","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/cid\/ciw051","article-title":"Protective effect of contemporary pertussis vaccines: a systematic review and meta-analysis","volume":"62","author":"Fulton","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.01.029_bib0020","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1097\/INF.0000000000000795","article-title":"Pertussis across the globe: recent epidemiologic trends from 2000 to 2013","volume":"34","author":"Tan","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jgar.2019.01.029_bib0025","first-page":"91","article-title":"Eight-year review of Bordetella pertussis testing reveals seasonal pattern in the United States","volume":"6","author":"Bhatti","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.jgar.2019.01.029_bib0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/QCO.0000000000000264","article-title":"Bordetella pertussis: new concepts in pathogenesis and treatment","volume":"29","author":"Carbonetti","year":"2016","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jgar.2019.01.029_bib0035","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1128\/AAC.45.12.3599-3600.2001","article-title":"Antimicrobial susceptibility testing of clinical isolates of Bordetella pertussis from northern California: report from the SENTRY Antimicrobial Surveillance Program","volume":"45","author":"Gordon","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.01.029_bib0040","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3201\/eid1806.120091","article-title":"Macrolide-resistant Bordetella pertussis infection in newborn girl France","volume":"18","author":"Guillot","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2019.01.029_bib0045","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1128\/JCM.41.3.1167-1172.2003","article-title":"Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance","volume":"41","author":"Bartkus","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2019.01.029_bib0050","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1128\/JCM.40.8.2942-2944.2002","article-title":"Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance","volume":"40","author":"Wilson","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2019.01.029_bib0055","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/1469-0691.12671","article-title":"High prevalence of erythromycin-resistant Bordetella pertussis in Xi\u2019an China","volume":"20","author":"Wang","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2019.01.029_bib0060","article-title":"Variation in Bordetella pertussis susceptibility to erythromycin and virulence-related genotype changes in China (1970\u20132014)","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jgar.2019.01.029_bib0065","doi-asserted-by":"crossref","first-page":"e1072","DOI":"10.1016\/j.ijid.2010.07.005","article-title":"Sensitivity and specificity of the World Health Organization pertussis clinical case definition","volume":"14","author":"Ghanaie","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.jgar.2019.01.029_bib0070","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1093\/cid\/ciw546","article-title":"Pertussis-associated pneumonia in infants and children from low- and middle-income countries participating in the PERCH study","volume":"63","author":"Barger-Kamate","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.01.029_bib0075","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/cid\/cis302","article-title":"Clinical definitions of pertussis: summary of a Global Pertussis Initiative roundtable meeting, February 2011","volume":"54","author":"Cherry","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.01.029_bib0080","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jpeds.2012.05.041","article-title":"California pertussis epidemic, 2010","volume":"161","author":"Winter","year":"2012","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.jgar.2019.01.029_bib0085","first-page":"953","article-title":"Recognizing the vaccination strategy of pertussis according to the family aggregation feature of transmission","volume":"35","author":"Li","year":"2014","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.jgar.2019.01.029_bib0090","doi-asserted-by":"crossref","first-page":"e1475","DOI":"10.1542\/peds.2014-3925","article-title":"Strategies to decrease pertussis transmission to infants","volume":"135","author":"Forsyth","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jgar.2019.01.029_bib0095","doi-asserted-by":"crossref","first-page":"21032","DOI":"10.2807\/1560-7917.ES2015.20.6.21032","article-title":"Surveillance of infant pertussis in Sweden 1998\u20132012; severity of disease in relation to the national vaccination programme","volume":"20","author":"Carlsson","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jgar.2019.01.029_bib0100","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1542\/peds.2014-2291","article-title":"First pertussis vaccine dose and prevention of infant mortality","volume":"135","author":"Tiwari","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jgar.2019.01.029_bib0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1542\/peds.100.1.65","article-title":"Seven days of erythromycin isolate is as effective as fourteen days for the treatment of Bordetella pertussis infections","volume":"100","author":"Halperin","year":"1997","journal-title":"Pediatrics"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519300360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519300360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:53:39Z","timestamp":1761990819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716519300360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":21,"alternative-id":["S2213716519300360"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2019.01.029","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin\/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: A single-centre study in Zhejiang Province, China","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2019.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}